MS

Mukesh Singh

Director Director DIN 06436891
DIN 06436891 First appointment Jul 2013 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukesh Singh

Data last updated:

Mukesh Singh was a Director at Genovia Plus Pharmaceuticals Private Limited (2015–2019) and Director at Crushtone Infratech Private Limited (from 2013). The companies operate in Healthcare.

DIN 06436891
Primary Designation Director
Industry Healthcare
First Appointment 08 Jul 2013
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Sep 20152015₹27.2 Lakh (FY 2020)Active
Crushtone Infratech Private Limited U70102UP2013PTC058220
Director08 Jul 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Crushtone Infratech Private Limited
Genovia Plus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mukesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukesh Singh

Mukesh Singh was first appointed on 08 Jul 2013 as Director at Crushtone Infratech Private Limited. The most recent appointment on record is 21 Sep 2015 at Genovia Plus Pharmaceuticals Private Limited.

Mukesh Singh held 2 earlier board appointments: Genovia Plus Pharmaceuticals Private Limited (Director, 21 Sep 2015 to 27 May 2019); Crushtone Infratech Private Limited (Director, from 08 Jul 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available